Surgeons often struggle with the decision of how aggressive a neck dissection should be when preoperative ultrasound provides ambiguous information about nodal involvement. This dilemma is particularly acute in the management of differentiated thyroid cancer, where papillary thyroid carcinoma (PTC)
While 6Ga-PSMA and 18F-DCFPyL are cornerstones of modern prostate cancer diagnostics, their effectiveness is limited by the respiratory 'blur' that occurs in the chest and abdomen. This phenomenon is a persistent technical obstacle in nuclear medicine because Positron Emission Tomography/Computed
Medical researchers at the University of Vienna are investigating whether dual-modality imaging can accurately identify which patients with elevated PSA levels truly require a biopsy. For decades, the standard protocol for suspected prostate cancer has relied heavily on the Prostate-Specific
Severe exertional dyspnea and intestinal obstruction marked the final stages of the patient's seventeen-month battle with this rare and invasive form of urethral malignancy. Primary urethral carcinoma remains one of the most elusive and devastating urological conditions, accounting for less than
The transition from intensity-based to volume-based metabolic assessment represents a significant shift in how oncologists might predict early treatment failure. While traditional staging systems rely heavily on tumor size and lymph node status, they often overlook the metabolic intricacies that
The diagnosis of metastatic medullary thyroid carcinoma is frequently hindered by the high physiological background activity of liver tissue in standard 18F-DOPA scans. This specific challenge is particularly problematic for patients with medullary thyroid carcinoma (MTC), a rare neuroendocrine